Get the Stockscreener App
1.51
0.67%
0.01
After Hours:
1.46
-0.05
-3.31%
Igm Biosciences Inc Stock (IGMS) Forecast
The Igm Biosciences Inc (IGMS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $57.94, representing a +3,737% increase from the current price of $1.51. The highest analyst price target is $69.72, and the lowest is $46.16.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IGMS Price Target
Average 76.85
(+4,989% Upside)
Is Igm Biosciences Inc (IGMS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 19.38 | Buy |
| STOCH(9,6) | 11.02 | Buy |
| STOCHRSI(14) | 74.12 | Neutral |
| MACD(12,26) | -1.5335 | Buy |
| ADX(14) | 50.50 | Sell |
| William %R | -91.04 | Buy |
| CCI(14) | -6.8439 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.631
Sell
|
1.85
Sell
|
| MA20 |
2.8993
Sell
|
2.8958
Sell
|
| MA50 |
6.2588
Sell
|
5.814
Sell
|
| MA100 |
10.58
Sell
|
8.1004
Sell
|
| MA200 |
9.8033
Sell
|
9.1637
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, IGMS could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on IGMS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 19.38 indicates that IGMS is oversold. This indicates that IGMS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 11.02 indicates that IGMS is oversold. This indicates that IGMS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 74.12 indicates that IGMS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 50.5 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -6.8439 indicates that IGMS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term IGMS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Igm Biosciences Inc financial reports and earnings history, Igm Biosciences Inc (IGMS) stock could reach $38.87 by 2030, $6.9048 by 2040 and $25.03 by 2050. See the projected annual prices until 2050 of the Igm Biosciences Inc stock below:
- Igm Biosciences Inc (IGMS) is expected to reach an average price of $12.28 in 2035, with a high prediction of $11.25 and a low estimate of $11.90. This indicates an $713.09% rise from the last recorded price of $1.51.
- Igm Biosciences Inc (IGMS) stock is projected to chart a bullish course in 2040, with an average price target of $6.3567, representing an $320.98% surge from its current level. The forecast ranges from a conservative $6.8366 to a sky-high $6.9048.
- Our analysts predict Igm Biosciences Inc (IGMS) to jump 434.82% by 2045, soaring from $11.83 to an average price of $8.0757, potentially reaching $11.69. While $11.83 is the low estimate, the potential upside is significant.
- Igm Biosciences Inc (IGMS) stock is expected to climb by 2050, reaching an average of $24.46, a $1,520% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.03 and $24.51, respectively, highlighting the market's uncertainty.
Igm Biosciences Inc Stock (IGMS) Year by Year Forecast
Igm Biosciences Inc Stock (IGMS) Price Forecast for 2025
Igm Biosciences Inc Stock (IGMS) is expected to reach an average price of $76.85 in 2025, with a high prediction of $122.85 and a low estimate of $30.85. This indicates an +4,989% rise from the last recorded price of $1.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $62.19 | $46.16 | $69.72 | +4,019% |
| April, 2025 | $39.58 | $36.28 | $67.56 | +2,521% |
| May, 2025 | $34.74 | $31.52 | $46.06 | +2,201% |
| June, 2025 | $73.39 | $30.85 | $79.32 | +4,760% |
| July, 2025 | $64.75 | $55.03 | $75.88 | +4,188% |
| August, 2025 | $43.86 | $31.70 | $66.04 | +2,805% |
| September, 2025 | $52.39 | $42.15 | $60.01 | +3,370% |
| October, 2025 | $74.67 | $49.85 | $122.85 | +4,845% |
| November, 2025 | $97.51 | $71.90 | $104.45 | +6,358% |
| December, 2025 | $77.99 | $59.81 | $117.18 | +5,065% |
Igm Biosciences Inc Stock (IGMS) Price Forecast for 2026
The predicted value for Igm Biosciences Inc (IGMS) in 2026 is set at an average of $48.53. Estimates vary from a peak of $89.94 to a trough of $7.1198, indicating an +3,114% surge from the present price of $1.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $67.87 | $59.23 | $86.15 | +4,395% |
| February, 2026 | $61.08 | $46.62 | $75.29 | +3,945% |
| March, 2026 | $65.10 | $46.46 | $67.00 | +4,212% |
| April, 2026 | $73.78 | $63.27 | $89.94 | +4,786% |
| May, 2026 | $76.33 | $68.26 | $84.65 | +4,955% |
| June, 2026 | $65.92 | $54.72 | $77.92 | +4,266% |
| July, 2026 | $65.71 | $57.60 | $74.39 | +4,252% |
| August, 2026 | $54.72 | $49.72 | $67.14 | +3,524% |
| September, 2026 | $51.24 | $35.88 | $56.09 | +3,293% |
| October, 2026 | $39.15 | $36.41 | $53.10 | +2,492% |
| November, 2026 | $20.63 | $16.71 | $45.15 | +1,266% |
| December, 2026 | $9.124 | $7.1198 | $21.79 | +504.24% |
Igm Biosciences Inc Stock (IGMS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Igm Biosciences Inc (IGMS) is $16.11, with a high forecast of $27.65 and a low forecast of $4.5785. This indicates an +967.05% increase from the last price of $1.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.7209 | $5.9909 | $11.12 | +411.32% |
| February, 2027 | $7.3779 | $4.7279 | $9.4036 | +388.60% |
| March, 2027 | $11.99 | $6.1113 | $27.65 | +693.98% |
| April, 2027 | $6.396 | $4.5785 | $12.08 | +323.57% |
| May, 2027 | $8.4429 | $6.1402 | $10.68 | +459.13% |
| June, 2027 | $10.42 | $4.6513 | $11.72 | +590.33% |
| July, 2027 | $8.261 | $8.151 | $13.41 | +447.08% |
| August, 2027 | $10.67 | $7.4252 | $19.46 | +606.48% |
| September, 2027 | $11.57 | $10.27 | $14.87 | +666.16% |
| October, 2027 | $11.86 | $10.41 | $18.15 | +685.16% |
| November, 2027 | $17.94 | $8.3487 | $18.81 | +1,088% |
| December, 2027 | $11.53 | $10.91 | $20.79 | +663.85% |
Igm Biosciences Inc Stock (IGMS) Price Forecast for 2028
In 2028, Igm Biosciences Inc (IGMS) is projected to reach an average price of $10.47, with a high projection of $20.75 and a low estimate of $0.2003. This indicates an +593.70% rise from the last price of $1.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.631 | $8.0568 | $13.41 | +537.81% |
| February, 2028 | $15.61 | $9.4352 | $20.75 | +933.64% |
| March, 2028 | $14.02 | $13.61 | $18.43 | +828.42% |
| April, 2028 | $8.476 | $8.316 | $15.42 | +461.33% |
| May, 2028 | $4.0472 | $2.9087 | $10.90 | +168.02% |
| June, 2028 | $4.6841 | $4.0714 | $7.3499 | +210.21% |
| July, 2028 | $3.071 | $3.011 | $7.1026 | +103.38% |
| August, 2028 | $3.7122 | $1.9403 | $4.468 | +145.84% |
| September, 2028 | $1.6091 | $1.2641 | $4.4364 | +6.56% |
| October, 2028 | $0.696 | $0.656 | $2.0176 | -53.90% |
| November, 2028 | $0.1728 | $0.2003 | $2.383 | -88.56% |
| December, 2028 | $2.1159 | $1.7786 | $1.7659 | +40.12% |
Igm Biosciences Inc Stock (IGMS) Price Forecast for 2029
The 2029 price forecast for Igm Biosciences Inc Stock (IGMS) is $17.24 on average, with a high prediction of $34.35 and a low estimate of $0.1271. This represents an +1,042% increase from the previous price of $1.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.8053 | $0.6789 | $1.1353 | -46.67% |
| February, 2029 | $2.5222 | $0.1271 | $3.6522 | +67.03% |
| March, 2029 | $4.7791 | $2.3364 | $6.7349 | +216.50% |
| April, 2029 | $8.8561 | $4.0276 | $10.28 | +486.49% |
| May, 2029 | $6.9872 | $5.9972 | $12.10 | +362.73% |
| June, 2029 | $3.3342 | $2.7599 | $7.1265 | +120.81% |
| July, 2029 | $4.3011 | $1.0369 | $5.1411 | +184.84% |
| August, 2029 | $5.5246 | $4.0787 | $5.7131 | +265.87% |
| September, 2029 | $0.3008 | $1.2738 | $5.2261 | -80.08% |
| October, 2029 | $0.6484 | $0.2254 | $5.6731 | -57.06% |
| November, 2029 | $17.85 | $0.6385 | $34.35 | +1,082% |
| December, 2029 | $13.06 | $8.5808 | $19.87 | +764.85% |
Igm Biosciences Inc Stock (IGMS) Price Forecast for 2030
Igm Biosciences Inc Stock (IGMS) is expected to reach an average price of $36.97 in 2030, with a high forecast of $68.83 and a low forecast of $5.1155. This signifies an +2,349% surge from the last price of $1.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $38.06 | $10.73 | $38.87 | +2,421% |
| February, 2030 | $23.96 | $5.1155 | $51.60 | +1,486% |
| March, 2030 | $42.59 | $18.45 | $47.76 | +2,720% |
| April, 2030 | $32.35 | $29.28 | $43.31 | +2,043% |
| May, 2030 | $38.02 | $29.13 | $46.15 | +2,418% |
| June, 2030 | $51.39 | $35.28 | $58.89 | +3,303% |
| July, 2030 | $28.89 | $25.59 | $56.81 | +1,813% |
| August, 2030 | $24.16 | $20.93 | $35.40 | +1,500% |
| September, 2030 | $62.90 | $20.28 | $68.83 | +4,066% |
| October, 2030 | $54.38 | $44.61 | $65.41 | +3,501% |
| November, 2030 | $33.59 | $21.41 | $55.69 | +2,125% |
| December, 2030 | $42.22 | $31.90 | $49.81 | +2,696% |
3.95%
2.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):